Paul J. Tiseo
Technik-/Wissenschafts-/F&E-Leiter bei COGNITION THERAPEUTICS, INC.
Aktive Positionen von Paul J. Tiseo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COGNITION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.10.2022 | - |
Karriereverlauf von Paul J. Tiseo
Ehemalige bekannte Positionen von Paul J. Tiseo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Ausbildung von Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Paul J. Tiseo
- Erfahrung
